Bojesen SE - Search Results

1

Circulating Protein Biomarkers for Use in Pancreatic Ductal Adenocarcinoma Identification.

Lindgaard SC, Sztupinszki Z, Maag E, Chen IM, Johansen AZ, Jensen BV, Bojesen SE, Nielsen DL, Hansen CP, Hasselby JP, Nielsen KR, Szallasi Z, Johansen JS. Lindgaard SC, et al. Among authors: bojesen se. Clin Cancer Res. 2021 May 1;27(9):2592-2603. doi: 10.1158/1078-0432.CCR-20-4215. Epub 2021 Mar 18. Clin Cancer Res. 2021. PMID: 33737308

2

Elevated plasma YKL-40 predicts increased risk of gastrointestinal cancer and decreased survival after any cancer diagnosis in the general population.

Johansen JS, Bojesen SE, Mylin AK, Frikke-Schmidt R, Price PA, Nordestgaard BG. Johansen JS, et al. Among authors: bojesen se. J Clin Oncol. 2009 Feb 1;27(4):572-8. doi: 10.1200/JCO.2008.18.8367. Epub 2008 Dec 15. J Clin Oncol. 2009. PMID: 19075264

3

Plasma YKL-40 and total and disease-specific mortality in the general population.

Johansen JS, Bojesen SE, Tybjaerg-Hansen A, Mylin AK, Price PA, Nordestgaard BG. Johansen JS, et al. Among authors: bojesen se. Clin Chem. 2010 Oct;56(10):1580-91. doi: 10.1373/clinchem.2010.146530. Epub 2010 Aug 26. Clin Chem. 2010. PMID: 20798353

4

Elevated plasma YKL-40 levels and ischemic stroke in the general population.

Kjaergaard AD, Bojesen SE, Johansen JS, Nordestgaard BG. Kjaergaard AD, et al. Among authors: bojesen se. Ann Neurol. 2010 Nov;68(5):672-80. doi: 10.1002/ana.22220. Ann Neurol. 2010. PMID: 21031582

5

Plasma YKL-40 levels in healthy subjects from the general population.

Bojesen SE, Johansen JS, Nordestgaard BG. Bojesen SE, et al. Clin Chim Acta. 2011 Apr 11;412(9-10):709-12. doi: 10.1016/j.cca.2011.01.022. Epub 2011 Jan 25. Clin Chim Acta. 2011. PMID: 21272568

6

Cancer risk by combined levels of YKL-40 and C-reactive protein in the general population.

Allin KH, Bojesen SE, Johansen JS, Nordestgaard BG. Allin KH, et al. Among authors: bojesen se. Br J Cancer. 2012 Jan 3;106(1):199-205. doi: 10.1038/bjc.2011.501. Epub 2011 Nov 17. Br J Cancer. 2012. PMID: 22095223 Free PMC article.

7

Diagnostic and Prognostic Impact of Circulating YKL-40, IL-6, and CA 19.9 in Patients with Pancreatic Cancer.

Schultz NA, Christensen IJ, Werner J, Giese N, Jensen BV, Larsen O, Bjerregaard JK, Pfeiffer P, Calatayud D, Nielsen SE, Yilmaz MK, Holländer NH, Wøjdemann M, Bojesen SE, Nielsen KR, Johansen JS. Schultz NA, et al. Among authors: bojesen se. PLoS One. 2013 Jun 26;8(6):e67059. doi: 10.1371/journal.pone.0067059. Print 2013. PLoS One. 2013. PMID: 23840582 Free PMC article.

8

Genetic variants in CHI3L1 influencing YKL-40 levels: resequencing 900 individuals and genotyping 9000 individuals from the general population.

Kjaergaard AD, Johansen JS, Nordestgaard BG, Bojesen SE. Kjaergaard AD, et al. Among authors: bojesen se. J Med Genet. 2013 Dec;50(12):831-7. doi: 10.1136/jmedgenet-2013-101908. Epub 2013 Sep 23. J Med Genet. 2013. PMID: 24062521

9

MicroRNA biomarkers in whole blood for detection of pancreatic cancer.

Schultz NA, Dehlendorff C, Jensen BV, Bjerregaard JK, Nielsen KR, Bojesen SE, Calatayud D, Nielsen SE, Yilmaz M, Holländer NH, Andersen KK, Johansen JS. Schultz NA, et al. Among authors: bojesen se. JAMA. 2014 Jan 22-29;311(4):392-404. doi: 10.1001/jama.2013.284664. JAMA. 2014. PMID: 24449318

10

YKL-40 and alcoholic liver and pancreas damage and disease in 86,258 individuals from the general population: cohort and mendelian randomization studies.

Kjaergaard AD, Bojesen SE, Nordestgaard BG, Johansen JS. Kjaergaard AD, et al. Among authors: bojesen se. Clin Chem. 2014 Nov;60(11):1429-40. doi: 10.1373/clinchem.2014.229096. Epub 2014 Sep 15. Clin Chem. 2014. PMID: 25225167

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

358 results

Search Page